ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients (2017)
Machado, Juliana; Nagai, Maria Aparecida; Fabro, Alexandre Todorovic; Capelozzi, Vera Luiza
Source: Journal of thoracic oncology. Conference titles: World conference on lun cancer - ASLC. Unidades: FM, FMRP
Subjects: NEOPLASIAS PULMONARES, ADENOCARCINOMA, PULMÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Juliana et al. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S. Acesso em: 16 maio 2024. , 2017
APA
Machado, J., Nagai, M. A., Fabro, A. T., & Capelozzi, V. L. (2017). Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
NLM
Machado J, Nagai MA, Fabro AT, Capelozzi VL. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S955.[citado 2024 maio 16 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Vancouver
Machado J, Nagai MA, Fabro AT, Capelozzi VL. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S955.[citado 2024 maio 16 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Trabalho de evento-resumo periodico
Digital drainage system reduces chest tube duration and hospitalization after anatomic pulmonary resectios for malignancies (2017)
Araujo, Pedro; Vega, Alberto Dela; Laurecella, Letícia; Bibas, Benoit; Fernandes, Paulo Manuel Pego; Terra, Ricardo Mingarini
Source: Journal of thoracic oncology. Conference titles: World conference on lun cancer - ASLC. Unidades: FM, FFLCH
Subjects: NEOPLASIAS PULMONARES, PULMÃO, DRENAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Pedro et al. Digital drainage system reduces chest tube duration and hospitalization after anatomic pulmonary resectios for malignancies. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S. Acesso em: 16 maio 2024. , 2017
APA
Araujo, P., Vega, A. D., Laurecella, L., Bibas, B., Fernandes, P. M. P., & Terra, R. M. (2017). Digital drainage system reduces chest tube duration and hospitalization after anatomic pulmonary resectios for malignancies. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
NLM
Araujo P, Vega AD, Laurecella L, Bibas B, Fernandes PMP, Terra RM. Digital drainage system reduces chest tube duration and hospitalization after anatomic pulmonary resectios for malignancies [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S1403-S1404.[citado 2024 maio 16 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Vancouver
Araujo P, Vega AD, Laurecella L, Bibas B, Fernandes PMP, Terra RM. Digital drainage system reduces chest tube duration and hospitalization after anatomic pulmonary resectios for malignancies [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S1403-S1404.[citado 2024 maio 16 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Trabalho de evento-resumo periodico
Immunohistochemical assessment of biomarkers for immune checkpoint inhibitors (2017)
Capelozzi, Vera Luiza
Source: Journal of thoracic oncology. Conference titles: World conference on lun cancer - ASLC. Unidade: FM
Subjects: NEOPLASIAS PULMONARES, IMUNOTERAPIA, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAPELOZZI, Vera Luiza. Immunohistochemical assessment of biomarkers for immune checkpoint inhibitors. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.jtho.2016.11.157. Acesso em: 16 maio 2024. , 2017
APA
Capelozzi, V. L. (2017). Immunohistochemical assessment of biomarkers for immune checkpoint inhibitors. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.jtho.2016.11.157
NLM
Capelozzi VL. Immunohistochemical assessment of biomarkers for immune checkpoint inhibitors [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S175-177.[citado 2024 maio 16 ] Available from: https://doi.org/10.1016/j.jtho.2016.11.157
Vancouver
Capelozzi VL. Immunohistochemical assessment of biomarkers for immune checkpoint inhibitors [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S175-177.[citado 2024 maio 16 ] Available from: https://doi.org/10.1016/j.jtho.2016.11.157
Trabalho de evento-resumo periodico
Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model (2017)
Teixeira, Lisete; Acencio, Milena; Alvarenga, Vanessa; Silva, Gabriela; Brito, Zenaide; Fernezlian, Sandra; Puka, Juliana; Martins, Juliana; Capelozzi, Vera
Source: Journal of thoracic oncology. Conference titles: World conference on lun cancer - ASLC. Unidade: FM
Subjects: ADENOCARCINOMA, DERRAME PLEURAL, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Lisete et al. Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S. Acesso em: 16 maio 2024. , 2017
APA
Teixeira, L., Acencio, M., Alvarenga, V., Silva, G., Brito, Z., Fernezlian, S., et al. (2017). Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
NLM
Teixeira L, Acencio M, Alvarenga V, Silva G, Brito Z, Fernezlian S, Puka J, Martins J, Capelozzi V. Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S1276-S1277.[citado 2024 maio 16 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Vancouver
Teixeira L, Acencio M, Alvarenga V, Silva G, Brito Z, Fernezlian S, Puka J, Martins J, Capelozzi V. Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S1276-S1277.[citado 2024 maio 16 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Trabalho de evento-resumo periodico
Differences between pleurodesis using talc and silver nitrate at differente times of pleural disease in mice (2017)
Sabbion, Rodrigo; Terra, Ricardo Mingarini; Teixeira, Lisete Ribeiro; Bonizzio, Carolina; Acencio, Milena; Fernandes, Paulo Manuel Pego
Source: Journal of thoracic oncology. Conference titles: World conference on lun cancer - ASLC. Unidade: FM
Subjects: PLEURODESE, NITRATOS, RATOS, DERRAME PLEURAL MALIGNO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABBION, Rodrigo et al. Differences between pleurodesis using talc and silver nitrate at differente times of pleural disease in mice. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S. Acesso em: 16 maio 2024. , 2017
APA
Sabbion, R., Terra, R. M., Teixeira, L. R., Bonizzio, C., Acencio, M., & Fernandes, P. M. P. (2017). Differences between pleurodesis using talc and silver nitrate at differente times of pleural disease in mice. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
NLM
Sabbion R, Terra RM, Teixeira LR, Bonizzio C, Acencio M, Fernandes PMP. Differences between pleurodesis using talc and silver nitrate at differente times of pleural disease in mice [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S1276-S1277.[citado 2024 maio 16 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Vancouver
Sabbion R, Terra RM, Teixeira LR, Bonizzio C, Acencio M, Fernandes PMP. Differences between pleurodesis using talc and silver nitrate at differente times of pleural disease in mice [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S1276-S1277.[citado 2024 maio 16 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Trabalho de evento-resumo periodico
13-gene signature of EMT reveals impact on invasion and metastasis of neuroendocrine carcinomas of the lung: a preliminary study (2017)
Prieto, Tabatha; Sá, Vanessa; Olivieri, Eloisa Helena Ribeiro; Silva, Eduardo da; Reis, Rui; Carraro, Dirce; Capelozzi, Vera Luiza
Source: Journal of thoracic oncology. Conference titles: World conference on lun cancer - ASLC. Unidade: FM
Subjects: NEOPLASIAS PULMONARES, METÁSTASE NEOPLÁSICA, CARCINOMA NEUROENDÓCRINO, CÉLULAS EPITELIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIETO, Tabatha et al. 13-gene signature of EMT reveals impact on invasion and metastasis of neuroendocrine carcinomas of the lung: a preliminary study. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.jtho.2016.11.939. Acesso em: 16 maio 2024. , 2017
APA
Prieto, T., Sá, V., Olivieri, E. H. R., Silva, E. da, Reis, R., Carraro, D., & Capelozzi, V. L. (2017). 13-gene signature of EMT reveals impact on invasion and metastasis of neuroendocrine carcinomas of the lung: a preliminary study. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.jtho.2016.11.939
NLM
Prieto T, Sá V, Olivieri EHR, Silva E da, Reis R, Carraro D, Capelozzi VL. 13-gene signature of EMT reveals impact on invasion and metastasis of neuroendocrine carcinomas of the lung: a preliminary study [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S712-S713.[citado 2024 maio 16 ] Available from: https://doi.org/10.1016/j.jtho.2016.11.939
Vancouver
Prieto T, Sá V, Olivieri EHR, Silva E da, Reis R, Carraro D, Capelozzi VL. 13-gene signature of EMT reveals impact on invasion and metastasis of neuroendocrine carcinomas of the lung: a preliminary study [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S712-S713.[citado 2024 maio 16 ] Available from: https://doi.org/10.1016/j.jtho.2016.11.939
Trabalho de evento-resumo periodico
Gene signature of EMT in neuroendocrine lung carcinoma: a comparative analysis with adenocarcinoma and squamous cell carcinoma (2017)
Prieto, Tabatha; Sá, Vanessa de; Olivieri, Eloisa Helena Ribeiro; Silva, Eduardo da; Reis, Rui; Carraro, Dirce; Capelozzi, Vera Luiza
Source: Journal of thoracic oncology. Conference titles: World conference on lun cancer - ASLC. Unidade: FM
Subjects: METÁSTASE NEOPLÁSICA, ADENOCARCINOMA, CARCINOMA NEUROENDÓCRINO, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIETO, Tabatha et al. Gene signature of EMT in neuroendocrine lung carcinoma: a comparative analysis with adenocarcinoma and squamous cell carcinoma. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S. Acesso em: 16 maio 2024. , 2017
APA
Prieto, T., Sá, V. de, Olivieri, E. H. R., Silva, E. da, Reis, R., Carraro, D., & Capelozzi, V. L. (2017). Gene signature of EMT in neuroendocrine lung carcinoma: a comparative analysis with adenocarcinoma and squamous cell carcinoma. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
NLM
Prieto T, Sá V de, Olivieri EHR, Silva E da, Reis R, Carraro D, Capelozzi VL. Gene signature of EMT in neuroendocrine lung carcinoma: a comparative analysis with adenocarcinoma and squamous cell carcinoma [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S714-S715.[citado 2024 maio 16 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Vancouver
Prieto T, Sá V de, Olivieri EHR, Silva E da, Reis R, Carraro D, Capelozzi VL. Gene signature of EMT in neuroendocrine lung carcinoma: a comparative analysis with adenocarcinoma and squamous cell carcinoma [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S714-S715.[citado 2024 maio 16 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects